Home>Topics>Companies>Express Scripts

Express Scripts ESRX

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. UPDATE 1- Express Scripts sees opportunity to lower cancer treatment cost

      Headlines

      Tue, 13 Jan 2015

      Jan 13 (Reuters) - Express Scripts , the largest U.S. pharmacy benefit manager, on Tuesday said cost savings on expensive cancer treatments could be achieved if the company were involved earlier in the decision-making process.

    2. Express Scripts sees opportunity to lower cancer treatment costs

      Headlines

      Tue, 13 Jan 2015

      Jan 13 (Reuters) - Express Scripts , the largest U.S. pharmacy benefit manager, on Tuesday said cost savings on expensive cancer treatments could be achieved if the company were involved earlier in...

    3. UPDATE 1-CVS to cover Gilead hepatitis C treatment over AbbVie regimen

      Headlines

      Mon, 5 Jan 2015

      (Recasts with attribution from CVS; adds Express Scripts , analyst comment, background)

    4. Our 2014 Big Pharma Pipeline Rankings: Who Came Out on Top?

      Video Reports

      Fri, 2 Jan 2015

      really had a lot of pricing pressure put on it by some of the major payers in the U.S., most notably [TICKER:ESRX] Express Scripts (ESRX). Because of that pricing pressure, we saw the projected forecast for Advair drop pretty dramatically and really

      Express Scripts found at 3:24

      it by some of the major payers in the U.S., most notably [TICKER:ESRX] Express Scripts (ESRX). Because of that pricing pressure, we saw the projected forecast for Advair drop pretty dramatically and really hurt the stock performance.
    5. Exclusive: Express Scripts presses for more drug savings with coverage list

      Headlines

      Tue, 23 Dec 2014

      LOS ANGELES (Reuters) - Express Scripts , the largest manager of prescription drug plans for U.S. employers, is taking an increasingly aggressive stance in price negotiations

    6. UPDATE 3- Express Scripts drops Gilead hep C drugs for cheaper AbbVie rival

      Headlines

      Mon, 22 Dec 2014

      Dec 22 (Reuters) - The largest U.S. pharmacy benefit manager said on Monday it has lined up a cheaper price for AbbVie Inc's newly approved hepatitis C treatment and, in most cases, will no longer cover Gilead Sciences Inc's treatments after trying for nearly a year to win a deeper discount.

    7. RPT-UPDATE 2- Express Scripts drops Gilead hep C drugs for cheaper AbbVie rival

      Headlines

      Mon, 22 Dec 2014

      Dec 22 (Reuters) - The largest U.S. pharmacy benefit manager said on Monday it has lined up a cheaper price for AbbVie Inc's newly approved hepatitis C treatment and, in most cases, will no longer cover Gilead Sciences Inc's treatments after trying for nearly a year to win a deeper discount.

    8. Any thoughts on GILD - Gilliad Sciences

      Commentary

      Mon, 22 Dec 2014

      It has tanked more than 10% this morning on the news that Express Scripts will buy HEp-C drugs from AbbVie only. Is it a good time to add to the current position or dump the shares? Thanks - SAM

    9. US STOCKS-Futures advance after three-day rally; data on tap

      Headlines

      Mon, 22 Dec 2014

      * Gilead falls as Express Scripts chooses AbbVie treatment

    « Prev12345Next »
    Content Partners